Claims Payable - Additional Information (Details) - USD ($) |
9 Months Ended | 12 Months Ended | |||
|---|---|---|---|---|---|
Sep. 30, 2021 |
Sep. 30, 2020 |
Dec. 31, 2020 |
Dec. 31, 2019 |
Dec. 31, 2018 |
|
| Claims Payable. | |||||
| IBNR | $ 75,108,251 | $ 52,154,556 | $ 56,934,400 | $ 19,859,348 | $ 7,801,556 |
| Total incurred claims | 416,228,369 | 295,275,661 | 418,103,177 | 119,091,765 | 79,982,717 |
| Difference between total incurred claims and total medical expenses | $ 43,004,716 | $ 52,982,611 | $ 67,409,966 | $ 22,350,692 | $ 12,499,060 |
| X | ||||||||||
- Definition Represents the difference between total incurred claims and total medical expenses. No definition available.
|
| X | ||||||||||
- Definition Estimated costs as of the balance sheet date of settling insured claims and costs incurred in the claims settlement process for claims that have not yet been submitted to the insurance company for reimbursement. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount, after effects of reinsurance, of expense (reversal of expense) for claims incurred and costs incurred in the claim settlement process. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- References No definition available.
|